Literature DB >> 8087762

Cancer in older persons. Magnitude of the problem--how do we apply what we know?

R Yancik1, L A Ries.   

Abstract

The elderly experience the major impact of cancer. The incidence rate for those aged 65 and older is 2085.3 per 100,000 as compared with 193.9 per 100,000 for those younger than 65. Overall, 58% of all cancer incidence is in the older segment of the population. Cancer mortality in the elderly now accounts for 67% of all cancer deaths. Data from the National Cancer Institute Surveillance, Epidemiology, and End Results program for 1985-1989 reveal many salient facts. Older persons have a risk of developing cancer 10 times greater than that for individuals younger than 65. This paper outlines the magnitude of the major cancers that affect the elderly. Incidence and mortality data are presented according to individual tumors (colon, rectum, lung/bronchus, pancreas, stomach, urinary bladder, breast, ovary, and prostate). Demographic data from the U.S. Bureau of the Census focus on the expanding elderly population in the United States and projections for the future. Needs for cancer care and treatment for the elderly, already great, are likely to increase. It is imperative that older persons receive special attention for cancer prevention, early diagnosis, and treatment efforts, especially because there is almost always an overlay of other chronic diseases and age-associated declines concurrent with the diagnosis of cancer in the elderly. This paper highlights issues unique to older persons as individuals at high risk for cancer and suggests research strategies that should be made in anticipation of the even greater cancer burden for the elderly as this subset of the population expands.

Entities:  

Mesh:

Year:  1994        PMID: 8087762     DOI: 10.1002/1097-0142(19941001)74:7+<1995::aid-cncr2820741702>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Cancer in the elderly: are we ready?

Authors:  D Khayat; G Auclerc
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

Review 2.  Bladder cancer in the elderly.

Authors:  Shahrokh F Shariat; Matthew Milowsky; Michael J Droller
Journal:  Urol Oncol       Date:  2009 Nov-Dec       Impact factor: 3.498

Review 3.  Familial pancreatic cancer.

Authors:  Gloria M Petersen
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

4.  [Palliative radiation oncologic therapy: is patient's age a determining factor of feasibility? A 1-year analysis (1997) at a radiotherapy clinic of an academic teaching hospital].

Authors:  R Souchon
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

5.  Predictors of cancer mortality in elderly subjects.

Authors:  A Mazza; E Casiglia; R Scarpa; V Tikhonoff; A Pizziol; E Sica; A C Pessina
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

Review 6.  Risk Factors for Adverse Outcome for Elderly Patients undergoing Curative Oncological Resection for Gastrointestinal Malignancies.

Authors:  Yukai K Lim; Christopher Jackson; Emilia L Dauway; Konrad Klaus Richter
Journal:  Visc Med       Date:  2017-08-10

Review 7.  Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient?

Authors:  Zeina Al-Mansour; Linda Pang; Venu Bathini
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 8.  Common cancers in the elderly.

Authors:  J Hansen
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

Review 9.  Adjuvant therapy for rectal cancer in the elderly.

Authors:  Seth M Cohen; Alfred I Neugut
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Rectal cancer surgery in the elderly: analysis of consecutive 158 patients with stage III rectal cancer.

Authors:  Tsukasa Hotta; Katsunari Takifuji; Shozo Yokoyama; Kenji Matsuda; Takashi Higashiguchi; Toshiji Tominaga; Yoshimasa Oku; Toru Nasu; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2007-06-26       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.